| (Values in U.S. Thousands) | Jun, 2024 | Mar, 2024 | Sep, 2023 | Jun, 2023 | Mar, 2023 |
| Sales | 0 | 0 | 500 | 450 | 16,682 |
| Sales Growth | unch | -100.00% | +11.11% | -97.30% | unch |
| Net Income | -1,065 | -807 | -3,243 | 68 | 12,699 |
| Net Income Growth | -31.97% | +75.12% | -4,869.12% | -99.46% | +593.93% |
Titan Medical Inc (TMD.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.
Fiscal Year End Date: 12/31